id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2008-P-0343-0024,FDA,FDA-2008-P-0343,"FDA Office of Policy to Novo Nordisk, Inc. - Petition Reconsideration & Petition for Stay of Action Denial",Other,PDN-Petition Denial,2009-06-18T04:00:00Z,2009,6,2009-06-18T04:00:00Z,,2013-07-27T22:47:20Z,,0,0,09000064809d2325
FDA-2008-P-0343-0022,FDA,FDA-2008-P-0343,"Exhibit 2 - ""Winston & Strawn LLP (on behalf of Caraco) to FDA/CDER, re: request for Correction, June 1, 2009""  - [Caraco Pharmaceuticals Laboratories, LTD - (Winston & Strawn LLP) - Reply Comment]  re FDA-2008-P-0343-0020",Supporting & Related Material,RC-Reply Comment (Supporting and Related Material),2009-06-17T04:00:00Z,2009,6,,,2009-06-18T00:17:05Z,,0,0,09000064809d01f3
FDA-2008-P-0343-0021,FDA,FDA-2008-P-0343,"Exhibit 1 - ""Caraco Letter to FDA/CDER , re: ANDA 77-571/Repaglinide, May 29, 2009"" - [Caraco Pharmaceuticals Laboratories, LTD - (Winston & Strawn LLP) - Reply Comment] re FDA-2008-P-0343-0020",Supporting & Related Material,RC-Reply Comment (Supporting and Related Material),2009-06-17T04:00:00Z,2009,6,,,2009-06-18T00:16:47Z,,0,0,09000064809d0622
FDA-2008-P-0343-0023,FDA,FDA-2008-P-0343,"Exhibit 3 - ""Caraco's Motion and Brief in Support of Motion Requesting Leave to Supplement Answer and CounterClaims, Civil Action No. 2:05 CV 40188""  - [Caraco Pharmaceuticals Laboratories, LTD - (Winston & Strawn LLP) - Reply Comment]  re FDA-2008-P-0343-0020",Supporting & Related Material,RC-Reply Comment (Supporting and Related Material),2009-06-17T04:00:00Z,2009,6,,,2009-06-18T00:15:48Z,,0,0,09000064809d01f5